Primary prevention of asthma in high-risk children using HDM SLIT: Assessment at age 6 years

J Allergy Clin Immunol. 2020 Jun;145(6):1711-1713. doi: 10.1016/j.jaci.2020.01.048. Epub 2020 Feb 12.

Abstract

Treatment of high-risk infants with HDM SLIT during early life resulted in a trend for reduction in asthma rates mid-childhood. This may be a viable preventative therapy for childhood asthma.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Sublingual
  • Animals
  • Asthma / immunology*
  • Asthma / prevention & control*
  • Child
  • Double-Blind Method
  • Female
  • Humans
  • Infant
  • Male
  • Primary Prevention / methods
  • Proof of Concept Study
  • Pyroglyphidae / immunology*
  • Sublingual Immunotherapy / methods